| Literature DB >> 27659439 |
Hyo Lim Hong1, Hwi In Koh2, A Jin Lee3.
Abstract
Corynebacterium species are non-fermentous Gram-positive bacilli that are normal flora of human skin and mucous membranes and are commonly isolated in clinical specimens. Non-diphtheriae Corynebacterium are regarded as contaminants when found in blood culture. Currently, Corynebacterium striatum is considered one of the emerging nosocomial agents implicated in endocarditis and serious infections. We report a case of native-valve infective endocarditis caused by C. striatum, which was misidentified by automated identification system but identified accurately by 16S ribosomal RNA sequencing, in a 55-year-old male patient. The patient had two mobile vegetations on his mitral valve, both of which had high embolic risk. Through surgical valve replacement and an antibiotic regimen, the patient recovered completely. In unusual clinical scenarios, C. striatum should not be simply dismissed as a contaminant when isolated from clinical specimens. The possibility of C. striatum infection should be considered even in an immunocompetent patient, and we suggest a genotypic assay, such as 16S rRNA sequencing, to confirm species identity.Entities:
Keywords: Corynebacterium; Endocarditis; RNA, Ribosomal, 16S
Year: 2016 PMID: 27659439 PMCID: PMC5048009 DOI: 10.3947/ic.2016.48.3.239
Source DB: PubMed Journal: Infect Chemother ISSN: 1598-8112
Figure 1Transesophageal echocardiogram findings.
Large, hypermobile vegetations were attached to the middle scallop of the anterior (arrowhead) and posterior mitral valve leaflets (arrow), 10 mm and 8 mm, respectively. Vegetation on the posterior mitral valve leaflet showed a 7 mm lineal mobile structure, which indicates a high embolic risk.
LA, left atrium; LV, left ventricle; Ao, aorta.
Reported cases of infective endocarditis caused by Corynebacterium striatum
| Year of publication | Age | Sex | Underlying disease | Prosthetic valve | Other medical device | Noso-comial risk factors | Affected valve | Echocardiography | Surgery | Antibiotic (s) administrated | Survival |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1990 | 76 | M | None | N | N | N | Aortic | Echocardiography | N | Ampicillin, gentamicin | N |
| 1994 | 54 | M | None | N | N | N | Aortic | TTE, TEE | AVR | Penicillin, gentamicin; vancomycin | Y |
| 1996 | 73 | M | Pacemaker (6 yr ago) | N | Y | Y | Tricuspid | TEE | Electrode lead removal | vancomycin | Y |
| 1996 | 24 | M | Congenital hydrocephalus, Ventriculo-atrial shunt state (age of 2 m) sacral bedsore | N | Y | Y | Pulmonary | TTE, TEE | N | Amoxicillin, netilmicin, teicoplanin | Y |
| 2002 | 68 | M | Mitral regurgitation, DM, CHF | N | N | N | Mitral | TTE, TEE | N | Vancomycin; penicillin | Y |
| 2002 | 62 | F | AVR (a few years ago) | Y | N | N | Aortic | TEE | N | vancomycin | Y |
| 2002 | 69 | F | ESRD via prosthetic arteriovenous fistula, ANCA-positive vasculitis | N | Y | Y | Mitral | TEE | MVR | Vancomycin, rifampin | N |
| 2002 | 50 | M | Surgery for mycotic aneurysm (2 m ago) | N | N | Y | Aortic | TEE | AVR | Vancomycin, gentamicin, doxycycline | Y |
| 2002 | 72 | F | AVR state (52 d ago), DM, IHD | Y | N | Y | Mitral | TTE | N | Vancomycin, gentamicin; penicillin | N |
| 2005 | 72 | F | MVR state (1990), culture-negative endocarditis (18 m ago), ANCA positive vasculitis, ARF on HD | Y | Maybe HD catheter | Y | Mitral | TEE | N | Vancomycin, rifampin | Y |
| 2005 | 61 | F | Cutaneous lupus, IHD | N | N | N | Mitral | TEE | N | Vancomycin, gentamicin | Y |
| 2005 | 46 | F | ESRD, graft-related infection | N | Y | Y | Tricuspid | TEE | N | Linezolid; daptomycin, rifampin | Y |
| 2006 | 68 | M | AVR (3 yr ago), MVR (1y ago), CHF, AF, CVA | Y | N | N | Mitral | TTE | N | Vancomycin | Y |
| 2006 | 69 | F | Endometrial cancer | N | N | Y | Mitral | TEE | MVR | Vancomycin | Y |
| 2006 | 77 | F | None | N | N | N | Mitral | Echocardiography | N | Medical | Y |
| 2007 | 62 | M | CRF, AF | N | N | Y | Aortic | TEE | AVR | Vancomycin | Y |
| 2008 | 83 | M | Metastatic prostate cancer | N | N | N | Mitral | TTE | N | Vancomycin, rifampin; penicillin, gentamicin; daptomycin | N |
| 2008 | 73 | F | CHF, CRF, DM | N | N | Y | Mitral | TTE, TEE | N | Vancomycin | Y |
| 2009 | 71 | M | DM | N | N | Y | Mitral | TEE | N | Vancomycin | N |
| 2010 | 71 | F | Pacemaker (2 m ago) | N | Y | Y | Pacemaker lead | TTE | Device removal | Daptomycin | Y |
| 2012 | 56 | M | DM, ESRD | N | N | Y | Mitral | TEE | MVR | Daptomycin; telavancin | N |
| 2013 | 78 | M | Pacemaker (6 m ago), DM, CRF | N | Y | N | Tricuspid | TTE | Electrode lead removal | Daptomycin | Y |
TTE, transthoracic echocardiography; TEE, transesophageal echocardiography; AVR, aortic valve replacement; yr, years; m, months; DM, diabetes mellitus; CHF, congestive heart failure; ESRD, end-stage renal disease; ANCA, anti-neutrophil cytoplasmic antibody; d, days; IHD, ischemic heart disease; MVR, mitral valve replacement; HD, hemodialysis; ARF, acute renal failure; AF, atrial fibrillation; CVA, cerebrovascular accident; CRF, chronic renal failure.